ClinicalTrials.gg
Not yet recruitingNCT07920965Updated Nov 6, 2026

Video-based Visual Feedback Combined With Task-oriented Physiotherapy Among Cerebral Palsy

An interventional study of Video-Based Visual Feedback + Task-Oriented Physiotherapy and Conventional Physiotherapy in Cerebral Palsy (CP), sponsored by Riphah International University. Not yet recruiting at 2 sites in Pakistan. Open to participants aged 5 Years to 12 Years. Per ClinicalTrials.gov, last updated 2026-11-06.

Sponsored by Riphah International University · Not applicable, Interventional, and Treatment

Updated Nov 6, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
5 Years to 12 Years
Sex
All
01

Study summary

To determine the effects of Video-based visual feedback combined with task oriented physiotherapy on gross motor function, balance and gait in children with spastic cerebral palsy.

02

Conditions studied

  • Cerebral Palsy (CP)

Browse trials for

Keywords

  • Spastic Cerebral Palsy
03

In context

Cerebral Palsy

1,936 studies on the registry are indexed under Cerebral Palsy; 458 are open to participants now.

This study's planned enrollment of 36 is close to the median of 34 across 1,431 interventional studies indexed under Cerebral Palsy.

Browse Cerebral Palsy studies →

Lead sponsor

Riphah International University is the lead sponsor of 2,193 studies on the registry; 650 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children diagnosed with spastic cerebral palsy.
  • Age between 5-12 years.
  • Gross Motor Function Classification System (GMFCS) levels I-III.
  • Ability to follow simple verbal commands.
  • Medically stable condition.
  • Ability to maintain sitting or standing with minimal assistance.
  • Have parental/guardian consent for participation

Exclusion criteria

Exclusion Criteria:

  • Severe visual or hearing impairments.
  • Orthopedic surgery within the previous 6 months.
  • Botulinum toxin injection within the previous 6 months.
  • Uncontrolled seizures or severe cognitive impairment.
  • Other neurological or musculoskeletal disorders affecting mobility.
  • Severe fixed deformities limiting participation.
  • Have severe cognitive impairment preventing participation
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
36 participants (estimated)

Study arms

  • Experimental
    Video-Based Visual Feedback + Task-Oriented Physiotherapy

    Other: Video-Based Visual Feedback + Task-Oriented Physiotherapy

  • Active comparator
    Conventional Physiotherapy

    Other: Conventional Physiotherapy

Interventions

  • OtherVideo-Based Visual Feedback + Task-Oriented Physiotherapy

    Participants in the experimental group will receive video-based visual feedback combined with task-oriented physiotherapy for a period of 6 weeks. The intervention will be administered three times per week, with each session lasting approximately 45 minutes

  • OtherConventional Physiotherapy

    Participants in the control group will receive conventional physiotherapy for a duration of 6 weeks. The treatment will be administered three times per week, with each session lasting approximately 45 minutes

06

What researchers measure

Primary outcomes

  1. Gross Motor Function Measure

    A standardized tool used to assess gross motor abilities in children with cerebral palsy. It measures activities such as sitting, crawling, standing, and walking. Scores range from 0-100, with higher scores indicating better motor function

    Time frame: 6 weeks

  2. Pediatric Balance Scale

    A balance assessment tool designed for children. It evaluates a child's ability to maintain balance during everyday activities such as standing, reaching, turning, and stepping. The Pediatric Balance Scale (PBS) has a maximum total score of 56 points (14 items × 4 points each). Higher scores indicate better balance performance.

    Time frame: 6 weeks

  3. Observational Gait Scale (OGS)

    A simple observational tool used to assess walking patterns in children with cerebral palsy. It evaluates different aspects of gait, such as foot placement, knee movement, and overall walking quality. The Observational Gait Scale (OGS) has a maximum total score of 22 points (6 items scored from 0-3 and 1 item scored from 0-4). Higher scores indicate a more normal gait pattern.

    Time frame: 6 weeks

07

Study locations

2 sites
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Jun 2027, 7 months later.

Of 902 non-industry interventional studies with no phase under Cerebral Palsy, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 31. This study's planned 7 months is below that.

Counting every sponsor, half of 921 studies reached it within 12 months; a quarter within 5 and three quarters within 31.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 2, 2026
First posted
Nov 6, 2026
StartEst.
Nov 2026
Primary completionEst.
Jun 2027
CompletionEst.
Jun 2027
Last update
Nov 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 6, 2026
Show all 1 update
  1. Nov 6, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07920965
Responsible party
Sponsor
First posted
Nov 6, 2026
Start date
Nov 2026 (estimated)
Primary completion
Jun 2027 (estimated)
Completion
Jun 2027 (estimated)
Last update
Nov 6, 2026

Study contacts

Qamar Mahmood, PhD
Contact
Qamar.mehmood@riphah.edu.pk
03335151063
Qamar Mahmood
principal investigator · Riphah International University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion